Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: Clover Corporation Limited

Market Cap 148M 104M 90.35M 83.68M 78.34M 147M 9.78B 993M 385M 4.81B 389M 381M 16.71B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 148M 104M 90.35M 83.68M 78.34M 147M 9.78B 993M 385M 4.81B 389M 381M 16.71B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.55x
Free-Float
81.15%
Yield 2026 *
2.02%
Yield 2027 * 2.7%
1 week+4.09%
Current month-1.66%
1 month+2.30%
3 months+15.58%
6 months+16.34%
Current year+12.66%
1 week 0.84
Extreme 0.845
0.9
1 month 0.8
Extreme 0.8
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.49
Extreme 0.49
1.16
3 years 0.34
Extreme 0.337
1.23
5 years 0.34
Extreme 0.337
1.88
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
11-18Sell

Chief Executive Officer

255,199 0.1528%
11-18Buy

Chief Executive Officer

529,638 0.3171%
11-06Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+4.09%+67.92%-26.45% 104M
-1.75%-6.95%+29.57%+81.00% 12.7B
-2.60%+3.10%-56.22%+122.10% 4.93B
+1.34%-0.71%-11.37%-59.65% 2.43B
+5.55%+7.14% - - 1.68B
-1.22%-3.64%-22.45%-27.40% 1.24B
+2.41%-1.57%+47.10%-4.42% 1.23B
+4.04%+0.48%-61.48%-65.92% 1.14B
+4.30%+7.38%-84.43%-73.69% 1.1B
-0.82%+0.88%-0.22%+23.83% 1.07B
Average +1.12%+0.75%-10.18%-3.40% 2.76B
Weighted average by Cap. -0.45%-2.25%-2.13%+50.57%

Financials

2026 *2027 *
Net sales 89.4M 62.68M 54.65M 50.62M 47.38M 88.86M 5.91B 600M 233M 2.91B 235M 230M 10.11B 95.3M 66.82M 58.26M 53.96M 50.51M 94.73M 6.3B 640M 248M 3.1B 251M 245M 10.78B
Net income - -
Net Debt - -
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
19/06/26 0.8900 $ 0.00% 32,163
18/06/26 0.8900 $ +2.01% 18,255
17/06/26 0.8725 $ +0.29% 13,376
16/06/26 0.8700 $ +0.58% 52,282
15/06/26 0.8650 $ +1.17% 59,915
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.8900AUD
Average target price
0.8700AUD
Spread / Average Target
-2.25%

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!